Your browser doesn't support javascript.
loading
Pulmonary cavitary disease due to Mycobacterium xenopi.
Abdallah, Yousri Ben; Belfeki, Nabil; Klopfenstein, Timothée; Zayet, Souheil.
Afiliación
  • Abdallah YB; Pneumology Department, Hôpital Nord Franche-Comté (HNFC), Belfort, France.
  • Belfeki N; Internal Medicine Department, Groupe Hospitalier Sud Ile de France, Melun, France.
  • Klopfenstein T; Infectious Diseases Department, Hôpital Nord Franche-Comté (HNFC), Belfort, France.
  • Zayet S; Infectious Diseases Department, Hôpital Nord Franche-Comté (HNFC), Belfort, France.
Infect Med (Beijing) ; 1(1): 63-66, 2022 Mar.
Article en En | MEDLINE | ID: mdl-38074974
ABSTRACT
Non-tuberculous mycobacteria are a significant cause of pulmonary infections worldwide and can be clinically challenging. Mycobacterium xenopi (M. xenopi) has a low pathogenicity and usually requires immunosuppression or lung diseases. We describe herein a scarce case of pulmonary cavitary disease attributed to M. xenopi in a 57-year-old Caucasian patient with underlying structural lung disease successfully treated with rifampicin, ethambutol, clarithromycin, and amikacin.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Infect Med (Beijing) Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Infect Med (Beijing) Año: 2022 Tipo del documento: Article País de afiliación: Francia
...